361 related articles for article (PubMed ID: 33644724)
1. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
[TBL] [Abstract][Full Text] [Related]
2. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
[TBL] [Abstract][Full Text] [Related]
4. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19.
Higuera-de la Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Chapa-Azuela O; Chávez-Morales A; Rosales-Salyano VH
Liver Res; 2021 Mar; 5(1):21-27. PubMed ID: 33520337
[TBL] [Abstract][Full Text] [Related]
5. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
[TBL] [Abstract][Full Text] [Related]
6. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
8. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. Effects of COVID-19 on the liver: The experience of a single center.
Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
[TBL] [Abstract][Full Text] [Related]
12. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and mechanism of liver injury in patients with mild or moderate coronavirus disease 2019.
Gomi K; Ito T; Yamaguchi F; Kamio Y; Sato Y; Mori H; Endo K; Abe T; Sakakura S; Kobayashi K; Shimada K; Noda J; Hibiki T; Ohta S; Sagara H; Tanaka A; Jinno M; Yamawaki M; Nishimoto F; Inoue K; Nagahama M
JGH Open; 2021 Aug; 5(8):888-895. PubMed ID: 34386596
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of liver injury in 445 patients with Corona Virus Disease-19-Single-centre experience from southern India.
Saithanyamurthi HV; Munirathinam M; Ananthavadivelu M
Indian J Gastroenterol; 2021 Jun; 40(3):303-308. PubMed ID: 33991309
[TBL] [Abstract][Full Text] [Related]
15. The Liver Can Deliver: Utility of Hepatic Function Tests as Predictors of Outcome in COVID-19, Influenza and RSV Infections.
Ritter E; Shusterman E; Prozan L; Kehat O; Weiss Meilik A; Shibolet O; Ablin JN
J Clin Med; 2023 May; 12(9):. PubMed ID: 37176775
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
17. Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury.
Lin Y; Yuan J; Long Q; Hu J; Deng H; Zhao Z; Chen J; Lu M; Huang A
Genes Dis; 2021 Jul; 8(4):484-492. PubMed ID: 33225036
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
20. Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
Tripon S; Bilbault P; Fabacher T; Lefebvre N; Lescuyer S; Andres E; Schmitt E; Garnier-KepKA S; Borgne PL; Muller J; Merdji H; Chaffraix F; Mutter D; Baumert TF; Meziani F; Doffoel M
Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101894. PubMed ID: 35227956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
